Our research, published in 2020 in Viruses (MDPI), titled ‘Comprehensive Evaluation of the Safety and Efficacy of BAFASAL® Bacteriophage Preparation for the Reduction of Salmonella

We are pleased to share the significant progress Proteon Pharmaceuticals made in 2024. Our company strengthened its market position, advanced its research initiatives, and expanded

Proteon Pharmaceuticals is delighted to announce that the Ministry of Agriculture, Livestock Farming and Supplies (MAPA) in Brazil has registered BAFASAL PRO, our latest bacteriophage-based

Proteon Pharmaceuticals is excited to announce that the European Food Safety Authority (EFSA) has published a positive scientific opinion on our innovative product BAFASAL®. The

At Proteon Pharmaceuticals S.A., we’re dedicated to supporting the growth of future scientists and professionals. This summer, we offered the internships to six students, eager

Proteon Pharmaceuticals is thrilled to announce the obtaining of a new European patent for our pioneering technology: “Method and Kit for Detection of Extraintestinal E.